WuXi PharmaTech (Cayman) Inc. A (NYSE:WX)

Thursday, September 22, 2016 | Web News
SHANGHAI and WUXI, China, Sept. 22, 2016 /PRNewswire/ -- WuXi Biologics, a leading open-access R&D capability and technology...
Friday, December 11, 2015 | Web News
SHANGHAI, Dec. 10, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access...
Tuesday, December 8, 2015 | Web News
SHANGHAI, China and RALEIGH, N.C., Dec. 07, 2015 (GLOBE NEWSWIRE) -- WuXi PharmaTech (Cayman) Inc. (...
See All Research...
Tuesday, August 25, 2015, 2:34 PM
Five Potentially Lucrative Opportunities in China-Based Company Go-Private Transactions
See All Articles and Reports...
Shanghai-based WuXi PharmaTech is the leading China-based pharmaceutical and biotechnology R&D outsourcing company. As a research- driven and customer-focused company, WuXi PharmaTech provides pharmaceutical and biotechnology companies a broad and integrated portfolio of laboratory and research manufacturing services throughout the drug discovery and development process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug discovery and development by providing cost-effective and efficient outsourcing solutions that save its customers both time and money. Its operations are grouped into two segments: laboratory services, consisting of discovery chemistry, service biology, analytical, pharmaceutical development and process development services, and manufacturing, focusing on manufacturing of advanced intermediates and active pharmaceutical ingredients for R&D use. (website)

Web site: http://www.wuxipharmatech.com

Last updated March 24, 2008


Market Data powered by QuoteMedia. Terms of Use